SS
NEO icon

SBI Securities’s NeoGenomics NEO Stock Holding History

SBI Securities’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6K Sell
1,344
-81
-6% -$782 ﹤0.01% 1557
2026
Q1 		$10.6K Buy
1,425
+41
+3% +$431 ﹤0.01% 1697
2025
Q4 		$16.3K Sell
1,384
-207
-13% -$2.23K ﹤0.01% 1527
2025
Q3 		$12.3K Sell
1,591
-293
-16% -$2.05K ﹤0.01% 1672
2025
Q2 		$13.8K Buy
1,884
+222
+13% +$1.79K ﹤0.01% 1557
2025
Q1 		$15.8K Buy
1,662
+109
+7% +$1.36K ﹤0.01% 1418
2024
Q4 		$25.6K Buy
+1,553
New +$24.1K ﹤0.01% 1242

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

SBI Securities's NEO Position: Q2 2026 in Review

SBI Securities reduced its NeoGenomics (NEO) stake by 5.7% in Q2 2026, selling an estimated $782 and leaving 1,344 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1557.

SBI Securities first reported a position in NEO in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.6K in Q4 2024. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • SBI Securities held 1,344 shares of NeoGenomics worth $19.6K as of Q2 2026.
  • SBI Securities sold 81 NeoGenomics shares in Q2 2026, an estimated $782.
  • NeoGenomics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1557 holding.
  • SBI Securities first reported a position in NeoGenomics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's NeoGenomics position peaked at $25.6K in Q4 2024.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.